Company overview
Resolve Biosciences offers Molecular Cartography™, a platform providing high-resolution spatial transcriptomics at subcellular resolution to map molecular interactions while preserving tissue samples. The technology supports applications in oncology, neuroscience, and infectious disease by enabling analysis of tumor heterogeneity, immune interactions, and biomarker development. Customers in North America and Europe can access commercial services for sample submission and data analysis.
Resolve Biosciences is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include spatial transcriptomics, molecular cartography, subcellular resolution, spatial biology, tumor heterogeneity.
Structured facts
- Website
- https://www.resolvebiosciences.com
- Markets served
- United States & Americas
- Keywords
- spatial transcriptomics, molecular cartography, subcellular resolution, spatial biology, tumor heterogeneity
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What is Molecular Cartography™?
- Molecular Cartography™ is a proprietary, highly multiplexed, single-molecule detection platform that delivers the highest-resolution view of subcellular gene expression and spatial biology, preserving sample tissue for future analysis.
- What are the key applications for pharma and life sciences?
- Applications include investigating tumor heterogeneity, immune cell states, ligand-receptor interactions, biomarker identification, and mapping complex tissue architectures in oncology, neuroscience, and infectious disease.
- What regions do they serve and how to access services?
- Resolve Biosciences provides commercial Molecular Cartography services to customers in North America and Europe through sample submission to their labs in Monheim am Rhein, Germany, and San Jose, California.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
